APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1:5,000 |
1:500 |
1:10,000 |
Note :
IHC-Fr
using immersion fixed human peripheral blood lymphocytes
|
Not tested in other applications.
Calculated MW
Positive Control
NGF-treated PC12, rat brain
PROPERTIES
Form
Liquid
Buffer
PBS, 1% BSA
Preservative
15mM Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
Batch dependent (Please refer to the vial label for the specific concentration.)
Antigen Species
Rat
Immunogen
synthetic peptide corresponding to the C-terminal of NGFR p75 of rat origin (amino acids 407-425 with N-terminally added lysine) conjugated to KLH.
Purification
Purified by affinity chromatography
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
nerve growth factor receptor , LNGFR , RNNGFRR , Tnfrsf16 , p75 , p75NTR
Cellular Localization
Membrane; Single-pass type I membrane protein
Background
Nerve Growth Factor Receptor, also termed NGFR p75 or p75NTR, is the low-affinity NGFR (LNGFR) which binds NGF and other neurotrophins including BDNF, NT3, NT4/5 with similar, low affinity. NGFR p75 is a 75kD transmembrane glycoprotein (399 a.a.) consisting of an extracellular domain (222 a.a.) which contains four cysteine-rich domains responsible for ligand binding, a transmembrane domain (22 a.a.), and a cytoplasmic domain (155 a.a.). NGFR p75 is mainly expressed in Schwann cells and neurons and in a variety of non-neuronal cells. NGFR p75 is necessary for regulating neuronal growth, migration, differentiation and cell death during development of the central and peripheral nervous system. The signal transduction mechanisms and components leading to NGFR p75 multiple signals are complex and not well understood. In contrast to other members of the neurotrophin receptors family (TrkA, TrkB and TrkC tyrosine kinases), NGFR p75 lacks intrinsic catalytic activity. It has been suggested that NGFR p75 interacts with TrkA to form high affinity binding sites and to modulate TrkA signaling. NGFR p75 belongs to the TNF receptor superfamily which includes TNFR, CD40 and Fas. These receptors all have an intracellular death domain and can couple to parallel signaling pathways leading to apoptotic cell death or activation of the transcription factor NF-kappaB. NGFR p75 plays a central role in the regulation of cell number by apoptosis in the developing CNS. During early development, activation of NGFR p75 by NGF induces apoptotic cell death in some neuronal cells, probably through activation of the sphingomyelinase/ceramide pathway, the ICE-like proteases and the JNK pathway. In rat Schwann cells, NGF binding to NGFR p75 activates NF-kappaB, possibly to modulate Schwann cell migration during nerve regeneration.
Database
Research Area
DATA IMAGES
|
GTX10494 ICC/IF Image
ICC/IF analysis of PC12 cells using GTX10494 p75 NGF Receptor / CD271 antibody at 1:500. Cells were fixed and permeabilized with methanol followed by methanol:acetone.
|
|
GTX10494 WB Image
WB analysis of various samples using GTX10494 p75 NGF Receptor / CD271 antibody at 1:5000.
Lane 1: Rat brain
Lane 2: 50 ng/ml NGF-differentiated PC12 cells
Lane 3: Negative control: non-treated PC12 cells
|
REFERENCE
There are currently no references for p75 NGF Receptor / CD271 antibody (GTX10494). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for p75 NGF Receptor / CD271 antibody (GTX10494). Be the first to share your experience with this product.